Los participantes que recibieron tirzepatida tambin mostraron reduccin significativa de la presin arterial sistlica y de la protena C reactiva
Sterile compounding required: Like semaglutide, compounded tirzepatide is an injectable and demands full USP 797 sterile compounding compliance
Brief flushing or dizziness possible with niacin
95% CI, 1.03-1.07)
Maintenance and discontinuation SURMOUNT-4, continue vs placebo switch after lead-in to about 20.9% loss: stopping regained about +14% over 52 weeks while continuing lost a further -5.5%
While circulating levels of PYY 3-36 are frequently reduced in individuals with obesity 31,32,33,34,35 , these levels typically return to those detected in average-weight individuals following a reduction in body weight and/or gastric bypass surgery 32,33,35